TOKYO -- Takeda Pharmaceutical plans to sell its Osaka headquarters to bolster its finances ahead of the planned purchase of Irish drugmaker Shire for nearly 7 trillion yen ($63 billion) .
Companies
Takeda to sell Osaka headquarters ahead of Shire purchase
Sale aimed at beefing up finances for the planned $63bn acquisition
